Grant of Options

Summary by AI BETAClose X

Equipmake Holdings plc has granted options to directors and employees over 105,622,723 ordinary shares at an exercise price of 1.40 pence per share, representing approximately 9.40% of the company's current issued share capital. These options are exercisable between September 2028 and September 2036, with vesting contingent on the volume weighted average price of the ordinary shares reaching 2.8p, 3.5p, and 4.2p. The Chief Executive Officer, Ian Foley, has undertaken not to exercise options in a way that would trigger a mandatory offer under Rule 9 of the Takeover Code, given his existing significant shareholding.

Disclaimer*

Equipmake Holdings PLC
08 September 2026
 

8 September 2026

Equipmake Holdings plc

 

("Equipmake" or the "Company")

 

Grant of Options

 

Equipmake, a market leader in engineering-driven differentiated electrification technologies, products and solutions for the off-highway, on-highway, and aerospace and defence sectors, announces the grant to directors and employees of options ("Options") on 7 September 2026 over a total of 105,622,723 Ordinary Shares of £0.0001 each in the Company ("Ordinary Shares"), including to the four Equipmake directors, under the Equipmake Share Option Plan.

 

On 31 July 2025 the Company announced its intention to issue Options exercisable at 1.40 pence per Ordinary Share to certain of its directors and employees and these Options have now been granted. The Options are exercisable at a price of 1.40 pence per Ordinary Share from 7 September 2028 until 7 September 2036, subject to the satisfaction of the performance conditions set out below. In the event of a general offer for the Company, the Options will become immediately exercisable in full, irrespective of whether the normal exercise date has been reached or any of the performance conditions have been satisfied:

 

1.    one third of the Ordinary Shares subject to each Option will become exercisable once the volume weighted average price of an Ordinary Share over 10 consecutive dealing days ("10 Day VWAP") has reached 2.8p;

2.    a further third of the Ordinary Shares subject to each Option will become exercisable once the 10 Day VWAP has reached 3.5p; and

3.    the remaining Ordinary Shares subject to each Option will become exercisable once the 10 Day VWAP has reached 4.2p.

 

The Ordinary Shares subject to the Options represent approximately 9.40% of the Company's current issued share capital.

 

The Options granted to directors of the Company are set out below. These total in aggregate 52,811,362 Options. The remaining 52,811,361 Options have been granted to senior employees of the Company who are not considered to be PDMRs.

 


Position

Number of Options granted

Total number of Options held post grant

Ian Foley

Chief Executive Officer

28,091,150

28,091,150

Jason Abbott

Chief Operating Officer

7,865,522

7,865,522

Tim Metcalfe

Non-Executive Chairman

11,236,460

11,236,460

Dena Bellamy

Non-Executive Director

5,618,230

5,618,230

 

Ian Foley, Chief Executive Officer of the Company, currently holds 382,581,343 Ordinary Shares, representing 34.05% of the Company's existing issued share capital. Under Rule 9 of the Takeover Code, while Mr Foley is interested in shares carrying 30% or more, but not more than 50%, of the voting rights of the Company, any acquisition by him of a further interest in Ordinary Shares which increases the percentage of voting rights in which he is interested may, in the absence of a waiver or other consent from the Takeover Panel, give rise to an obligation to make a mandatory offer for the remaining Ordinary Shares of the Company. Accordingly, Mr Foley has irrevocably undertaken to the Company not to exercise any of his Options to the extent that such exercise would result in an obligation arising under Rule 9 of the Takeover Code.

 

The information in the below notification is disclosed in accordance with Article 19 of the UK Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.    Ian Foley

2.    Jason Abbott

3.    Timothy Mark Metcalfe

4.    Dena Bellamy

 

2.

Reason for the Notification

a)

Position/status

1.    Chief Executive Officer

2.    Chief Operating Officer

3.    Non-Executive Chairman

4.    Non-Executive Director

 

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Equipmake Holdings plc

b)

LEI

213800NY1WGJ26E4HB59

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.0001 each



Identification Code

GB00BMBVXB73

b)

Nature of the transaction

Grant of Options

 

c)

Price(s) and volume(s)


Price(s)

Volume(s)

1.

1.40 pence per Ordinary Share

28,091,150 Options over Ordinary Shares

2.

1.40 pence per Ordinary Share

7,865,522 Options over Ordinary Shares

3.

1.40 pence per Ordinary Share

11,236,460 Options over Ordinary Shares

4.

1.40 pence per Ordinary Share

5,618,230 Options over Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

 

N/A

e)

Date of the transaction

7 September 2026

 

f)

Place of the Transaction

Outside a Trading Venue

 

 

For further information, please contact:

 

Equipmake

Tim Metcalfe, Non-Executive Chairman

Ian Foley, CEO

Via IFC

VSA Capital (Financial Adviser, Aquis Corporate Adviser and Broker)

Andrew Raca / Brian Wong

Tel: +44 (0) 20 3005 5000

 

IFC Advisory (Financial PR and IR Adviser)

Graham Herring / Zach Cohen

Tel: +44 (0)20 3934 6632

equipmake@investor-focus.co.uk

 

Sign up for Equipmake updates here: https://investors.equipmake.co.uk/auth/signup

 

About Equipmake

 

Equipmake is a UK-based industrial technology company specialising in the engineering, development and production of electrification products to meet the needs of the automotive and other sectors in support of the transition from fossil-fuelled to zero-emission drivetrains.

 

Equipmake is a leader in high performance technologically advanced electric motors, inverters and complete zero-emission electric drivetrains and power electronic systems. Equipmake has developed a vertically integrated solution providing fully bespoke solutions to its customers. The Company is focussed on accelerating traction with OEM and Tier 1 suppliers in relation to higher margin component and drivetrain supply under long-term growth contracts.

 

Key differentiators of the Company offerings are its advanced technology and performance, reliability and adherence to ASIL-D1 functional safety. Equipmake's advanced motor and inverter technology, featuring ASIL-D compliance, are designed to customers' highest functional safety standards. With decades of experience in electric drivetrain integration and a dedicated prototype vehicle testing facility, Equipmake can significantly accelerate product development for customers.

 

Further investor and background information may be found on the Company's website, including video interviews and interested parties can sign up to follow the company at:

https://investors.equipmake.co.uk/

 

1 Automotive Safety Integrity Level ("ASIL") is a risk classification scheme defined by the ISO 26262 - Functional Safety for Road Vehicles standard and is a critical requirement for road vehicles. Of the four ASILs identified by the standard, ASIL-D dictates the highest integrity requirements on the product, which require exceptional rigour in their development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings